Acute treatment with pyrrolo(1,4)benzodiazepine antitumor antibiotics alters in vitro hepatic drug metabolizing activity in rats

John E. Atkinson, William C. Lubawy

Research output: Contribution to journalArticle

Abstract

The pyrrolo(1,4)benzodiazepine antitumor antibiotic, anthramycin, shares a number of toxicities with the widely used anticancer agent adriamycin. We investigated whether acute doses of anthramycin and the structurally related compounds, sibiromycin and tomaymycin, would depress P-450-dependent drug biotransformations as has been reported for adriamycin. Alterations in drug metabolism rates were determined in rats using 50 and 75% of the approximate 7-day LD50 determined in mice. 4 days post dosing ethylmorphine demethylase and aniline hydroxylase activities in liver 9000 g supernatant were depressed from 26 to 76%. Tomaymycin lowered drug metabolism in a dose-related manner, while sibiromycin produced the greatest amount of depression. Like adriamycin, the pyrrolo(l,4)benzo-diazepines possess the ability to depress hepatic drug metabolism and therefore may affect the disposition of compounds with which they are co-administered.

Original languageEnglish
Pages (from-to)337-342
Number of pages6
JournalToxicology Letters
Volume18
Issue number3
DOIs
StatePublished - 1 Jan 1983

Fingerprint

Anthramycin
Rats
Metabolism
Doxorubicin
Anti-Bacterial Agents
Liver
Pharmaceutical Preparations
Ethylmorphine
Aniline Hydroxylase
Lethal Dose 50
Biotransformation
Antineoplastic Agents
Toxicity
Bz-423
In Vitro Techniques
sibiromycin
tomaymycin

Keywords

  • aniline hydroxylase
  • Anthramycin
  • ethylmorphine n-demethylase
  • hepatic drug metabolizing activity
  • sibiromycin
  • tomaymycin

Cite this

@article{76f3e9e99bd743f4bf2fc8a707300cad,
title = "Acute treatment with pyrrolo(1,4)benzodiazepine antitumor antibiotics alters in vitro hepatic drug metabolizing activity in rats",
abstract = "The pyrrolo(1,4)benzodiazepine antitumor antibiotic, anthramycin, shares a number of toxicities with the widely used anticancer agent adriamycin. We investigated whether acute doses of anthramycin and the structurally related compounds, sibiromycin and tomaymycin, would depress P-450-dependent drug biotransformations as has been reported for adriamycin. Alterations in drug metabolism rates were determined in rats using 50 and 75{\%} of the approximate 7-day LD50 determined in mice. 4 days post dosing ethylmorphine demethylase and aniline hydroxylase activities in liver 9000 g supernatant were depressed from 26 to 76{\%}. Tomaymycin lowered drug metabolism in a dose-related manner, while sibiromycin produced the greatest amount of depression. Like adriamycin, the pyrrolo(l,4)benzo-diazepines possess the ability to depress hepatic drug metabolism and therefore may affect the disposition of compounds with which they are co-administered.",
keywords = "aniline hydroxylase, Anthramycin, ethylmorphine n-demethylase, hepatic drug metabolizing activity, sibiromycin, tomaymycin",
author = "Atkinson, {John E.} and Lubawy, {William C.}",
year = "1983",
month = "1",
day = "1",
doi = "10.1016/0378-4274(83)90115-7",
language = "English",
volume = "18",
pages = "337--342",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "3",

}

Acute treatment with pyrrolo(1,4)benzodiazepine antitumor antibiotics alters in vitro hepatic drug metabolizing activity in rats. / Atkinson, John E.; Lubawy, William C.

In: Toxicology Letters, Vol. 18, No. 3, 01.01.1983, p. 337-342.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Acute treatment with pyrrolo(1,4)benzodiazepine antitumor antibiotics alters in vitro hepatic drug metabolizing activity in rats

AU - Atkinson, John E.

AU - Lubawy, William C.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The pyrrolo(1,4)benzodiazepine antitumor antibiotic, anthramycin, shares a number of toxicities with the widely used anticancer agent adriamycin. We investigated whether acute doses of anthramycin and the structurally related compounds, sibiromycin and tomaymycin, would depress P-450-dependent drug biotransformations as has been reported for adriamycin. Alterations in drug metabolism rates were determined in rats using 50 and 75% of the approximate 7-day LD50 determined in mice. 4 days post dosing ethylmorphine demethylase and aniline hydroxylase activities in liver 9000 g supernatant were depressed from 26 to 76%. Tomaymycin lowered drug metabolism in a dose-related manner, while sibiromycin produced the greatest amount of depression. Like adriamycin, the pyrrolo(l,4)benzo-diazepines possess the ability to depress hepatic drug metabolism and therefore may affect the disposition of compounds with which they are co-administered.

AB - The pyrrolo(1,4)benzodiazepine antitumor antibiotic, anthramycin, shares a number of toxicities with the widely used anticancer agent adriamycin. We investigated whether acute doses of anthramycin and the structurally related compounds, sibiromycin and tomaymycin, would depress P-450-dependent drug biotransformations as has been reported for adriamycin. Alterations in drug metabolism rates were determined in rats using 50 and 75% of the approximate 7-day LD50 determined in mice. 4 days post dosing ethylmorphine demethylase and aniline hydroxylase activities in liver 9000 g supernatant were depressed from 26 to 76%. Tomaymycin lowered drug metabolism in a dose-related manner, while sibiromycin produced the greatest amount of depression. Like adriamycin, the pyrrolo(l,4)benzo-diazepines possess the ability to depress hepatic drug metabolism and therefore may affect the disposition of compounds with which they are co-administered.

KW - aniline hydroxylase

KW - Anthramycin

KW - ethylmorphine n-demethylase

KW - hepatic drug metabolizing activity

KW - sibiromycin

KW - tomaymycin

UR - http://www.scopus.com/inward/record.url?scp=0020501552&partnerID=8YFLogxK

U2 - 10.1016/0378-4274(83)90115-7

DO - 10.1016/0378-4274(83)90115-7

M3 - Article

C2 - 6689384

AN - SCOPUS:0020501552

VL - 18

SP - 337

EP - 342

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 3

ER -